Press "esc" to clear
Go to Advanced Search

Showing results

110 of 911

Article ID: 702127

Dodge The Flu: Get Vaccinated

Texas A&M University

It’s that time of year again: time to get your flu vaccination. Here’s what you need to know to stay ahead this flu season.

12-Oct-2018 1:05 PM EDT
Embargo will expire:
16-Oct-2018 9:00 AM EDT
Released to reporters:
12-Oct-2018 1:00 PM EDT


A reporter's PressPass is required to access this story until the embargo expires on 16-Oct-2018 9:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 702115

Is the Next Big Step in Cancer Therapy Personalized Vaccines?

University of California San Diego Health

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

12-Oct-2018 10:05 AM EDT

Article ID: 702044

Do mobile messages about HPV work?

University of Georgia

New research from the University of Georgia suggests that in the case of HPV, health care providers shouldn’t place too much faith in the smart device alone to get their message across.

11-Oct-2018 11:05 AM EDT
  • Embargo expired:
    11-Oct-2018 5:00 AM EDT

Article ID: 701803

Lassa Fever Vaccine Shows Promise and Reveals New Test for Immunity

Thomas Jefferson University

A new Lassa fever and rabies vaccine shows lasting immunity and suggests a new way to test for protection.

8-Oct-2018 11:05 AM EDT

Article ID: 701983

The Medical Minute: Preparing for flu season

Penn State Health Milton S. Hershey Medical Center

Experts say it's always better to get the flu vaccine than not.

10-Oct-2018 11:05 AM EDT
  • Embargo expired:
    10-Oct-2018 10:00 AM EDT

Article ID: 701959

Synthetic DNA Vaccine Against Ebola Virus Shows Potent and Long-term Efficacy in Preclinical Studies

Wistar Institute

A novel synthetic DNA vaccine developed based on technology pioneered by Wistar scientists offers complete protection from Zaire Ebolavirus (EBOV) infection in promising preclinical research.

10-Oct-2018 9:10 AM EDT

Article ID: 701811

Vaccinating humans to protect mosquitoes from malaria

University at Buffalo

For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach — in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten — is called a transmission-blocking vaccine (TBV). A new biotech advancement moves us closer to this goal. If successful, it could help reduce the spread of the disease, which kills more than 400,000 people annually.

8-Oct-2018 12:05 PM EDT

Showing results

110 of 911

Chat now!